Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Int J Tuberc Lung Dis ; 28(3): 130-135, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38454180

ABSTRACT

INTRODUCTIONTo determine the frequency of TB among patients with interstitial lung diseases (ILDs).METHODSWe performed a comprehensive search in the PubMed/Medline, EMBASE and Scopus databases up to 1 August 2023 of studies reporting on the prevalence of TB among patients with ILDs.RESULTSTwelve studies comprising 3,817 patients with ILD were found: the pooled prevalence of TB among ILD patients was 11.0% (95% CI 5.4-21.0). In the subgroup analysis, the TB rate among patients with silicosis and idiopathic pulmonary fibrosis (IPF) was respectively 35.6% (95% CI 32.6-38.8) and 4.4% (95% CI 3.6-5.3) (P = 0.00). The frequency of TB among ILD patients was higher in high TB burden countries than in low/intermediate-burden countries: 26.3%, 95% CI 17.7-37.3 vs. 4.9%, 95% CI 3.3-7.2; P = 0.00.CONCLUSIONSThis study shows the frequency of TB among ILD patients. The meta-analysis reveals a significantly increased prevalence of TB among ILD patients with silicosis compared to IPF, and among individuals in high TB burden countries than in those with low/intermediate burden. The study results can help physicians and policymakers make efficient decisions for prompt screening and anti-TB treatment initiation in ILD patients..


Subject(s)
Idiopathic Pulmonary Fibrosis , Lung Diseases, Interstitial , Silicosis , Tuberculosis , Humans , Tuberculosis/epidemiology , Prevalence , Lung Diseases, Interstitial/epidemiology , Silicosis/epidemiology , Idiopathic Pulmonary Fibrosis/epidemiology
2.
Ultrasound J ; 12(1): 43, 2020 Sep 07.
Article in English | MEDLINE | ID: mdl-32893335

ABSTRACT

BACKGROUND: Point-of-care Ultrasound (POCUS) is becoming an important diagnostic tool for internal medicine and ultrasound educational programs are being developed. An ultrasound course is often included in such a curriculum. We have performed a prospective observational questionnaire-based cohort study consisting of participants of a POCUS course for internal medicine in the Netherlands in a 2-year period. We investigated the usefulness of an ultrasound course and barriers participants encountered after the course. RESULTS: 55 participants (49%) completed the pre-course questionnaire, 29 (26%) completed the post-course questionnaire, 11 participants (10%) finalized the third questionnaire. The number of participants who performs POCUS was almost doubled after the course (from 34.5 to 65.5%). Almost all participants felt insufficiently skilled before the course which declined to 34.4% after the course. The majority (N = 26 [89.7%]) stated that this 2-day ultrasound course was sufficient enough to perform POCUS in daily practice but also changed daily practice. The most important barriers withholding them from performing ultrasound are lack of experts for supervision, insufficient practice time and absence of an ultrasound machine. CONCLUSIONS: This study shows that a 2-day hands-on ultrasound course seems a sufficient first step in an ultrasound curriculum for internal medicine physicians to obtain enough knowledge and skills to perform POCUS in clinical practice but it also changes clinical practice. However, there are barriers in the transfer to clinical practice that should be addressed which may improve curriculum designing.

3.
Injury ; 2020 Oct 17.
Article in English | MEDLINE | ID: mdl-34756305

ABSTRACT

OBJECTIVE: Tension Pneumothorax (TP) can occur as a potentially life threatening complication of chest trauma. Both the 2nd intercostal space in the midclavicular line (ICS2-MCL) and the 4th/5th intercostal space in the anterior axillary line (ICS 4/5-AAL) have been proposed as preferred locations for needle decompression (ND) of a TP. In the present study we aim to determine chest wall thickness (CWT) at ICS2-MCL and ICS4/5-AAL in normal weight-, overweight- and obese patients, and to calculate theoretical success rates of ND for these locations based on standard catheter length. METHODS: We performed a prospective multicenter study of a convenience sample of adult patients presenting in Emergency Departments (ED) of 2 university hospitals and 6 teaching hospitals participating in the XXX consortium. CWT was measured bilaterally in ISC2-MCL and ISC4/5-AAL with point of care ultrasound (POCUS) and hypothetical success rates of ND were calculated for both locations based on standard equipment used for ND. RESULTS: A total of 392 patients was included during a 2 week period. Mean age was 51 years (range 18-89), 52% was male and mean BMI was 25.5 (range 16.3-45.0). Median CWT was 26 [IQR 21-32] (range 9-52) mm in ISC2-MCL, and 26 [21-33] (range 10-78) mm in ICS4/5-AAL (p<0.001). CWT in ISC2-MCL was significantly thinner than ICS4/5-AAL in overweight- (BMI 25-30, p<0.001), and obese (BMI>30, p=0.016 subjects, but not in subjects with a normal BMI. Hypothetical failure rates for 45mm Venflon and 50mm Angiocatheter were 2.5% and 0.8% for ICS2-MCL and 6.2% and 2.5% for ISC4/5-AAL (p=0.016 and p=0.052 respectively). CONCLUSION: In overweight- and obese subjects, the chest wall is thicker in ICS 4/5-AAL than in ICS2-MCL and theoretical chances of successful needle decompression of a tension pneumothorax are significantly higher in ICS2-MCL compared to ICS 4/5-AAL.

4.
Neth J Med ; 77(5): 168-176, 2019 06.
Article in English | MEDLINE | ID: mdl-31264587

ABSTRACT

The use of Point-of-care Ultrasound (PoCUS) is rapidly increasing in internal medicine as it is useful in the primary assessment of acutely ill internal medicine patients for enhanced diagnostics and resuscitation. PoCUS can be taught in a modular fashion including basic core applications and advanced applications which can be combined for a symptom-based approach. Several PoCUS curriculum guidelines, especially for emergency medicine, exist throughout the world but a clear Dutch guideline for internists has not been developed. In this review we propose 'core' ultrasound competencies for internists that may also be incorporated into the European Training Requirements Internal Medicine. We suggest the use of an Entrustable Professional Activities (EPA) competencybased training system with EPAs specifically designed for ultrasound.


Subject(s)
Curriculum/standards , Emergency Medicine , Internal Medicine , Point-of-Care Testing/standards , Ultrasonography , Clinical Competence , Emergency Medicine/education , Emergency Medicine/methods , Humans , Internal Medicine/education , Internal Medicine/methods , Needs Assessment , Ultrasonography/methods , Ultrasonography/standards
5.
PLoS One ; 8(12): e82703, 2013.
Article in English | MEDLINE | ID: mdl-24367544

ABSTRACT

The determination of the myocardium's tissue properties is important in constructing functional finite element (FE) models of the human heart. To obtain accurate properties especially for functional modeling of a heart, tissue properties have to be determined in vivo. At present, there are only few in vivo methods that can be applied to characterize the internal myocardium tissue mechanics. This work introduced and evaluated an FE inverse method to determine the myocardial tissue compressibility. Specifically, it combined an inverse FE method with the experimentally-measured left ventricular (LV) internal cavity pressure and volume versus time curves. Results indicated that the FE inverse method showed good correlation between LV repolarization and the variations in the myocardium tissue bulk modulus K (K = 1/compressibility), as well as provided an ability to describe in vivo human myocardium material behavior. The myocardium bulk modulus can be effectively used as a diagnostic tool of the heart ejection fraction. The model developed is proved to be robust and efficient. It offers a new perspective and means to the study of living-myocardium tissue properties, as it shows the variation of the bulk modulus throughout the cardiac cycle.


Subject(s)
Heart Ventricles/physiopathology , Models, Theoretical , Algorithms , Elasticity , Finite Element Analysis , Humans , Myocardium/metabolism
6.
Childs Nerv Syst ; 20(1): 29-36, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14605840

ABSTRACT

OBJECTIVE: In neonatal lambs, the quantitative evidence suggests that a significant volume of cranial CSF drainage is associated with transport along olfactory nerves with absorption primarily into extracranial lymphatics in the paranasal region. Arachnoid granulations appear to be poorly developed at this level of development and their function is unknown. In this report, we tested whether a CSF protein tracer ((131)I-human serum albumin) could transport directly into the superior sagittal sinus of newborn lambs. METHODS AND RESULTS: The concentration of the tracer administered into the CSF compartment was measured in the confluence of the intracranial venous sinuses (torcula) and in the peripheral blood (inferior vena cava). Enrichment of the CSF tracer in the cranial venous system was most evident when the CSF-venous sinus pressure gradients approached 20-30 cm H(2)O. CONCLUSION: The data suggests that neonatal CSF can be absorbed directly into the cranial venous system. However, contrary to the classical view, this route may represent an auxiliary system that is recruited to compliment lymphatic transport when intracranial pressures are very high.


Subject(s)
Absorption/physiology , Cerebrospinal Fluid/physiology , Analysis of Variance , Animals , Animals, Newborn , Biological Transport/physiology , Cerebrospinal Fluid/metabolism , Cerebrospinal Fluid Pressure/physiology , Evans Blue/pharmacokinetics , Female , Humans , Intracranial Pressure/physiology , Iodine Isotopes/metabolism , Male , Random Allocation , Serum/metabolism , Sheep , Silicone Elastomers/pharmacokinetics , Sinus of Valsalva/physiology , Time Factors
7.
Chem Commun (Camb) ; (23): 2422-3, 2001 Dec 07.
Article in English | MEDLINE | ID: mdl-12239996

ABSTRACT

The first use of silicon-29 diffusion-ordered NMR spectroscopy (DOSY) is reported, in a study of the speciation of aqueous silicates.

8.
Am J Physiol Regul Integr Comp Physiol ; 278(6): R1441-5, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10848509

ABSTRACT

We tested the hypothesis that hypertension in atrial natriuretic peptide (ANP) knockout mice is caused in part by disinhibition of angiotensin II-mediated vasopressin release. Inactin-anesthetized F(2) homozygous ANP gene-disrupted mice (-/-) and wild-type (+/+) littermates were surgically prepared for carotid arterial blood pressure measurement (ABP) and background intravenous injection of physiological saline or vasopressin V(1)-receptor antagonist (Manning compound, 10 ng/g body wt) and subsequent intracerebroventricular (left lateral ventricle) injection of saline (5 microl) or ANP (0.5 microg) or angiotensin II AT(1)-receptor antagonist losartan (10 microg). Only (-/-) showed significant decrease in ABP after intracerebroventricular ANP or losartan. Both showed significant hypotension after intravenous V(1) antagonist, but there was no difference between their responses. We conclude that 1) vasopressin contributes equally to ABP maintenance in ANP-disrupted mice and wild-type controls; 2) permanently elevated ABP in ANP knockouts is associated with increased central nervous angiotensin II AT(1)-receptor activation; 3) disinhibition of central nervous angiotensin II AT(1) receptors in ANP-deficient animals does not lead to a significant increase in the importance of vasopressin as a mechanism for blood pressure maintenance.


Subject(s)
Atrial Natriuretic Factor/genetics , Hypertension/genetics , Hypertension/physiopathology , Receptors, Angiotensin/physiology , Vasopressins/blood , Angiotensin II/physiology , Animals , Antihypertensive Agents/pharmacology , Arginine Vasopressin/analogs & derivatives , Arginine Vasopressin/pharmacology , Atrial Natriuretic Factor/pharmacology , Blood Pressure/drug effects , Blood Pressure/physiology , Female , Hormone Antagonists/pharmacology , Injections, Intravenous , Losartan/pharmacology , Male , Mice , Mice, Knockout , Paraventricular Hypothalamic Nucleus/physiology , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2
9.
Pharmacol Toxicol ; 81(3): 124-9, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9335069

ABSTRACT

In the present study, effect of cholecystokinin (CCK) agonists and on dependence to morphine in mice has been investigated. The influence of dopaminergic, adrenergic, cholinergic and serotonergic on attenuation of naloxone-induced jumping in morphine-dependent mice by CCK agonists were also considered. Mice were treated subcutaneously with morphine (50, 50 and 75 mg/kg) three times daily (10 a.m. 1 p.m. and 4 p.m.) for 3 days, and a last dose of morphine (50 mg/kg) was administered on the 4th day. Withdrawal syndrome (jumping) was precipitated by naloxone (5 mg/kg) which was administered intraperitoneally 2 hr after the last dose of morphine. To study effects of CCK receptor agonists, 10 injection of morphine (3 administrations each day) for dependence and a dose of 5 mg/kg of naloxone for withdrawal induction were employed. The CCK agonists CCK-8 (0.001-0.1 mg/kg), unsulfated CCK-8 (CCK-8U; 0.001-0.1 mg/kg) and caerulein (0.00001-0.01 mg/kg) were able to prevent withdrawal signs precipitated by naloxone (5 mg/kg). Sulpiride and pimozide increased response induced by CCK-8 agonists. The dopamine antagonists also attenuates jumping by themselves. SCH 23390 did not alter the CCK-8 effect, but decreased the jumping by itself. Phenoxybenzamine, propranolol, methysergide and atropine did not change the caerulein effect significantly. However, single administration of atropine increased and methysergide decreased jumping. It is concluded that CCK mechanism(s) may be involved in morphine dependence, and dopaminergic mechanism(s) may interact with CCK in attenuation of naloxone-induced jumping.


Subject(s)
Adrenergic Antagonists/therapeutic use , Dopamine Antagonists/therapeutic use , Morphine Dependence/drug therapy , Muscarinic Antagonists/therapeutic use , Receptors, Cholecystokinin/agonists , Serotonin Antagonists/therapeutic use , Substance Withdrawal Syndrome/drug therapy , Adrenergic Antagonists/pharmacology , Animals , Atropine/pharmacology , Benzazepines/pharmacology , Ceruletide/pharmacology , Dopamine Antagonists/pharmacology , Male , Methysergide/pharmacology , Mice , Morphine/adverse effects , Movement Disorders/etiology , Muscarinic Antagonists/pharmacology , Naloxone/administration & dosage , Narcotic Antagonists/administration & dosage , Phenoxybenzamine/pharmacology , Pimozide/pharmacology , Propranolol/pharmacology , Serotonin Antagonists/pharmacology , Sincalide/pharmacology , Sulpiride/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...